Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Preventing Diabetes with Antihypertensives
Black & Hispanic Americans Develop Diabetes Earlier in Life
Processed Versus Intact Whole Grains and Glycemic Control
Preventing Misdiagnosis between Type 1 and Type 2
New Screening Tool to Prevent Mortality from Complications of Foot Ulcers
Letter from the Editor
We are all familiar with the triad of diseases expected in diabetes patients. As soon as someone is diagnosed, we start to worry about cardiovascular and renal problems. In addition, we often swing our prescribing for these patients to the SGLT-2 inhibitors, as they have proven to be both cardio and renal protective. But if these diabetes drugs can help with hypertension, then is it possible that hypertensive drugs like ACE’s and ARB’s can help with diabetes control or prevention?
Our Creighton University, School of Pharmacy and Health Professions intern and PharmD candidate, Kevin Suarez, has found some retrospective studies looking at the idea of using ACE’s and ARB’s to prevent diabetes. Not to let the cat out of the bag, but there is a good reason to read his feature and follow the process. Click here to read it.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES — Diabetes News and Research
Researchers showed that elevated blood pressure is a modifiable risk factor for new-onset type 2 diabetes.
The mean age at diagnosis of diabetes for non-Hispanic Black and Hispanic adults was 4-7 years earlier than for non-Hispanic white adults.
Many foods are marked with the whole-grain stamp of approval, but are these products equivalent in terms of glycemic control?
A program testing type 1 diabetes patients’ C-peptide levels found that approximately half of the group had a different form of diabetes.
Risk factors associated with diabetic foot ulcers (DFU) are easily found in medical records, giving clinicians a tool for early detection.
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter:
Quinlynn Champ, PharmD Candidate Class of 2022, South College School of Pharmacy
Dalia Elabed, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy
Erica Hicks, PharmD Candidate 2022, South College School of Pharmacy
Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022
Jessica Rogers, PharmD Candidate, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Kevin Suarez, PharmD. Candidate, Creighton University, School of Pharmacy and Health Professions
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com